Sequent Scientific Limited

NSE:SEQUENT.NS

172.56 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 13,697.3114,209.0914,101.7213,520.3511,605.1310,205.298,419.578,944.726,295.874,406.564,537.743,260.863,458.13,116.652,844.481,440.21747.96447.21
Cost of Revenue 10,718.588,337.678,444.367,365.626,384.135,744.364,8314,842.313,539.452,591.062,845.382,120.521,920.381,620.161,276.48665.45545.578303.642
Gross Profit 2,978.735,871.425,657.366,154.735,2214,460.933,588.574,102.412,756.421,815.51,692.361,140.341,537.721,496.491,568774.76202.382143.568
Gross Profit Ratio 0.2170.4130.4010.4550.450.4370.4260.4590.4380.4120.3730.350.4450.480.5510.5380.2710.321
Reseach & Development Expenses 00000013.85124.588.5696.87115.3765.82000012.84.69
General & Administrative Expenses 0540.26500.31455.06380.48312.59297.95266.5149.28107.46112.362.4000028.2213.74
Selling & Marketing Expenses 0281.33276.76217.38237.79141.34177.85157.93142.78115.386142.72000022.545.97
SG&A 2,901.81821.59777.07672.44618.27453.93475.8424.43292.06222.84173.3105.12000050.7619.71
Other Expenses 109.5763.9-51.74-30.79-83.07-60.99-44.18-114.67-53.23-2.59-37.42-24.761,291.95238.02956.4850.6577.9944.801
Operating Expenses 2,901.816,140.954,978.854,347.913,837.163,430.132,982.483,563.962,485.741,797.661,637.361,350.741,291.951,181.53956.4850.65141.55429.201
Operating Income 76.92-153.46579.621,687.571,252.291,062.59667.08-14.22-212.91-699.16-1,099.14-741.21245.77314.96611.6-75.8960.828114.367
Operating Income Ratio 0.006-0.0110.0410.1250.1080.1040.079-0.002-0.034-0.159-0.242-0.2270.0710.1010.215-0.0530.0810.256
Total Other Income Expenses Net -623.38-1,223.12-50.32-321.28-311.54-473.75-430.63-406.08-351.52-496.88-979.47-308.82-299.9-280.07-216.65-50.52-23.747-2.951
Income Before Tax -546.46-1,376.59533.861,366.29940.75588.84236.456.38-169.64-633.19-1,099.14-727.5-54.1334.89394.95-126.4137.081111.416
Income Before Tax Ratio -0.04-0.0970.0380.1010.0810.0580.0280.001-0.027-0.144-0.242-0.223-0.0160.0110.139-0.0880.050.249
Income Tax Expense -250.33-156.81183.26321.77120.2920.07134.57-4.1328.2133.95.79-80.58-39.5475.1385.2620.1811.85858.628
Net Income -358.69-1,211.599409.55954.42699.05486.64,215.66-138.24-221.56-107.38-1,104.93-646.94-13.99-1.76374.17-146.5925.21885.75
Net Income Ratio -0.026-0.0850.0290.0710.060.0480.501-0.015-0.035-0.024-0.243-0.198-0.004-0.0010.132-0.1020.0340.192
EPS -1.44-4.881.673.872.87217.4-0.58-1.06-0.75-8.55-5.7-0.13-0.0163.52-2.640.511.52
EPS Diluted -1.44-4.841.653.852.851.9917.28-0.57-1.04-0.75-8.55-5.7-0.13-0.0163.52-2.640.511.52
EBITDA 692.32-10.751,182.072,204.771,784.821,292.44994.66963.78673.88304.14191.97-51.11475.58521.86850.7-11.185.731128.165
EBITDA Ratio 0.051-0.0010.0840.1630.1540.1270.1180.1080.1070.0690.042-0.0160.1380.1670.299-0.0080.1150.287